Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00560703
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:18.136175+00:00
Published At
2012-01-11T00:00:00+00:00
Record Updated At
2021-02-18
Results Posted At
2012-01-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Blepharitis", "Meibomianitis", "Dry Eye"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-02-18"
protocolSection.identificationModule.nctId
"NCT00560703"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2012-01-11"

Study condition terms

  • Blepharitis (protocolSection.conditionsModule.conditions)
  • Meibomianitis (protocolSection.conditionsModule.conditions)
  • Dry Eye (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.